Skip to main content

The independent source for health policy research, polling, and news.

The independent source for health policy research, polling, and news.

Subscribe Follow Us Conference Centers Donate

Search for:

Topics
Topics
Affordable Care Act

Elections

Global Health Policy

Health Costs

Health Information and Trust

HIV/AIDS

Immigrant Health

LGBTQ

Medicaid

Medicare

Mental Health

Patient and Consumer Protections

Public Opinion

Private Insurance

Racial Equity and Health Policy

State Health Policy and Data

Uninsured

Women's Health Policy

FEATURED CONTENT

Calculator: Expiring ACA Enhanced Tax Credits & Premiums

Peterson-KFF Health System Tracker
Explore all Topics
Policy Research

Policy Research

KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.

Explore all Policy Research
Polling

Polling

KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.

View all Poll Findings
Health News

Health News

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.

Explore KFF Health News
Data & Features
Data & Features
FROM THE CEO

From Drew Altman

Beyond the Data

FEATURES

Calculator: ACA Enhanced Premium Tax Credit

Employer Health Benefits Survey

Health Policy 101

The Health Wonk Shop

Medicaid Budget Survey

The Monitor

POLLING

KFF Health Tracking Poll

Survey of Women Voters

Women's Health Survey

FAQS

Health Insurance Marketplace and the ACA

Medicare Open Enrollment

TRACKERS

ACA Preventive Services Tracker

Global Health Budget Tracker

Medicaid Waiver Tracker

Peterson-KFF Health System Tracker

DASHBOARDS

Abortion in the U.S.

COVID-19 Vaccine Monitor

Key Data on Health Care by Race and Ethnicity

DATABASES

State Health Facts

Custom State Reports

STATE FACT SHEETS

Medicaid Fact Sheets

Mental Health and Substance
Use Fact Sheets

State Health Care Snapshots

STATE PROFILES

State Profiles of Dual-Eligible Individuals

State Profiles of Women’s Health
View all Features
For Media
For Media
Media Contacts

Citations and Reprints

News Releases

Explore all Media Resources
About
About
About Us

Our People

Our Work

Board of Trustees

Conference Centers

Events

Contact Us

Join Our Team

From CEO Drew Altman

President's Message

Our Standards & Practices

Beyond the Data Columns

View All
About KFF

Follow Us Subscribe

Search for:

Trending

ACA Open Enrollment
Health Policy 101
Tax and Budget Law
Quick Takes

Home Prescription Drugs Tags

View the Latest: Prescription Drugs

Filter

Past Week
Past Month
Past 6 Months
Past Year
Custom
Start Date

End Date

Clear Selections

Affordable Care Act (121)
COVID-19 (19)
Elections (41)
Global Health Policy (7)
Health Costs (308)
Health Information and Trust (2)
HIV/AIDS (26)
Immigrant Health (4)
LGBTQ (2)
Medicaid (182)
Medicare (470)
Mental Health (15)
Other Health (14)
Patient and Consumer Protections (12)
Private Insurance (64)
Public Opinion (192)
Racial Equity and Health Policy (15)
State Health Policy and Data (29)
Uninsured (70)
Women's Health Policy (32)

Clear Selections

Event (26)
Fact Sheet (13)
Feature (81)
From Drew Altman (12)
Interactive (1)
Issue Brief (217)
News Release (104)
Other Post (37)
Perspective (11)
Policy Watch (19)
Poll Finding (115)
Quick Take (10)
Report (156)
State Health Facts Indicator (9)
Video (3)

Clear Selections

Beyond the Data (2)
Employer Health Benefit Survey (27)
Health Policy 101 (1)
Health System Tracker (25)
Health Tracking Poll (59)
Health Wonk Shop (5)
KFF Health News Announcements (1)
KFF/NPR Surveys (8)
KFF/Washington Post Surveys (2)
Medicaid Budget Survey (11)
The Monitor (1)
Women's Health Survey (1)

Filter

Past Week
Past Month
Past 6 Months
Past Year
Custom
Start Date

End Date

Clear Selections

Affordable Care Act (121)
COVID-19 (19)
Elections (41)
Global Health Policy (7)
Health Costs (308)
Health Information and Trust (2)
HIV/AIDS (26)
Immigrant Health (4)
LGBTQ (2)
Medicaid (182)
Medicare (470)
Mental Health (15)
Other Health (14)
Patient and Consumer Protections (12)
Private Insurance (64)
Public Opinion (192)
Racial Equity and Health Policy (15)
State Health Policy and Data (29)
Uninsured (70)
Women's Health Policy (32)

Clear Selections

Event (26)
Fact Sheet (13)
Feature (81)
From Drew Altman (12)
Interactive (1)
Issue Brief (217)
News Release (104)
Other Post (37)
Perspective (11)
Policy Watch (19)
Poll Finding (115)
Quick Take (10)
Report (156)
State Health Facts Indicator (9)
Video (3)

Clear Selections

Beyond the Data (2)
Employer Health Benefit Survey (27)
Health Policy 101 (1)
Health System Tracker (25)
Health Tracking Poll (59)
Health Wonk Shop (5)
KFF Health News Announcements (1)
KFF/NPR Surveys (8)
KFF/Washington Post Surveys (2)
Medicaid Budget Survey (11)
The Monitor (1)
Women's Health Survey (1)

191 - 200 of 774 Results

Changes to Medicare Part D in 2024 and 2025 Under the Inflation Reduction Act and How Enrollees Will Benefit

Apr 20, 2023
Issue Brief

The Inflation Reduction Act of 2022 includes several provisions to lower prescription drug costs for people with Medicare and reduce drug spending by the federal government, including a number of changes to the Medicare Part D drug benefit. This brief provides an overview of the Part D benefit design and Part D enrollee cost-sharing requirements in 2023 and changes coming in 2024 and 2025.
2024 Employer Health Benefits Survey

Oct 9, 2024
Report

This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, worker contributions, cost-sharing provisions, offer rates, and more. This year’s report also looks at how employers are addressing a growing need for mental health services.
2024 Employer Health Benefits Chart Pack

Oct 9, 2024
Feature

This slideshow captures key data from the 2024 KFF Employer Health Benefits Survey survey, providing a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing, abortion coverage, offer rates, wellness programs, and other employer practices.
Medicare Part D Premiums Are Increasing for Many But Not All Stand-Alone Plans in 2025, Reflecting Effects of New Premium Stabilization Demonstration

Oct 3, 2024
Policy Watch

This policy watch examines monthly premiums for Medicare Part D stand-alone drug plans in 2025, as changes to the Part D benefit are being implemented in 2025, including a new $2,000 cap on out-of-pocket drug spending.
Why is There So Much Attention on Obesity Drugs?

Sep 24, 2024
Quick Take

High U.S. prices and demand for Ozempic and Wegovy have implications for insurance premiums, public program costs, and affordability.
Nearly 7 in 10 Medicare Beneficiaries Did Not Compare Plans During Medicare’s Open Enrollment Period

Sep 26, 2024
Issue Brief

This brief examines the share of Medicare beneficiaries who reviewed their coverage and compared plans during the open enrollment period for 2022 (that takes place in the Fall of 2021), and who made use of Medicare’s official information resources, as well as variations by demographic groups. Overall, nearly 7 in 10 Medicare beneficiaries did not compare their own source of Medicare coverage with other Medicare options offered in their area.
KFF Health Tracking Poll September 2024: Support for Reducing Prescription Drug Prices Remains High, Even As Awareness of IRA Provisions Lags

Sep 13, 2024
Feature

More than two years ago President Biden signed into law Medicare drug pricing provisions in the Inflation Reduction Act. KFF's September Health Tracking Poll examines voter's views on these provisions and finds that large majorities of voters are unaware of the provisions despite reporting support for them.
How Many People with Employer-Sponsored Insurance Use the Drugs Slated for Medicare Price Negotiations

Aug 14, 2024
Issue Brief

Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations, according to a new analysis.
Harris is Reframing Health as an Economic Issue

Aug 21, 2024
From Drew Altman

In his latest column, KFF President and CEO Drew Altman describes how Vice President Harris has reframed health as a pocketbook economic issue, which aligns with voters’ concern about health care costs.
While Medicare Drug Price Negotiations Don’t Apply to Private Insurance, 3.4 Million People with Employer Coverage Take at Least One of the Selected Drugs

Aug 14, 2024
News Release

Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations.

Posts pagination

1 … 19 20 21 … 78

Policy Research
Polling
Health News

About Us

Conference Centers
Join Our Team
Contact Us
Follow Us

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up

Privacy Policy
Citations and Reprints

© 2025 KFF